Importantly, while autoimmunity and loss of β-cell function, as measured by C-peptide and insulin levels, starts in the pre-symptomatic stages, preservation of remaining β-cell function at the time of clinical diagnosis can provide clinical benefits such as reductions in hypoglycemia, neuropathy and retinopathy (3). The gene discussed is INS; the disease is retinal disorder.